{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:47:16Z","timestamp":1789602436412,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.taap.2011.02.004","type":"journal-article","created":{"date-parts":[[2011,2,12]],"date-time":"2011-02-12T05:02:37Z","timestamp":1297486957000},"page":"165-175","source":"Crossref","is-referenced-by-count":68,"title":["Comparison of imatinib, nilotinib and silymarin in the treatment of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis"],"prefix":"10.1016","volume":"252","author":[{"given":"Mohamed E.","family":"Shaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled R.","family":"Zalata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajahat Z.","family":"Mehal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal E.","family":"Shiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek M.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2011.02.004_bb0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1755-1536-2-2","article-title":"Regression of fibrosis in paediatric autoimmune hepatitis: morphometric assessment of fibrosis versus semiquantiatative methods","volume":"2","author":"Abdalla","year":"2009","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.taap.2011.02.004_bb0010","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1096\/fj.07-105627","article-title":"Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis","volume":"22","author":"Akhmetshina","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.taap.2011.02.004_bb0015","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1164\/rccm.200404-531OC","article-title":"Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice","volume":"171","author":"Aono","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.taap.2011.02.004_bb0020","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0003-2697(83)90580-8","article-title":"A rapid biuret assay for protein of whole fatty tissues","volume":"129","author":"Beyer","year":"1983","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.taap.2011.02.004_bb0025","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1515\/znc-2001-7-826","article-title":"Mechanism of carbon tetrachloride-induced hepatotoxicity. Hepatocellular damage by reactive carbon tetrachloride metabolites","volume":"56","author":"Boll","year":"2001","journal-title":"Z. Naturforsch. C"},{"key":"10.1016\/j.taap.2011.02.004_bb0030","doi-asserted-by":"crossref","first-page":"39609","DOI":"10.1074\/jbc.M305770200","article-title":"Glutathione peroxidase 1 is regulated by the c-Abl and Arg tyrosine kinases","volume":"278","author":"Cao","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2011.02.004_bb0035","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1053\/j.ajkd.2008.08.029","article-title":"Imatinib in the treatment of nephrogenic systemic fibrosis","volume":"53","author":"Chandran","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.taap.2011.02.004_bb0040","first-page":"935","article-title":"Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia","volume":"8","author":"Cohen","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2011.02.004_bb0045","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1172\/JCI200419603","article-title":"Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis","volume":"114","author":"Daniels","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2011.02.004_bb0050","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrrheum.2009.82","article-title":"Tyrosine kinases as targets for the treatment of rheumatoid arthritis","volume":"5","author":"D'Aura Swanson","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.taap.2011.02.004_bb0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2008.10.014","article-title":"Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib","volume":"599","author":"Day","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2011.02.004_bb0060","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/j.clinthera.2008.11.014","article-title":"Nilotinib: a second-generation tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia","volume":"30","author":"Deremer","year":"2008","journal-title":"Clin. Ther."},{"issue":"Suppl 5","key":"10.1016\/j.taap.2011.02.004_bb0065","doi-asserted-by":"crossref","first-page":"v10","DOI":"10.1093\/rheumatology\/ken276","article-title":"Intracellular tyrosine kinases as novel targets for anti-fibrotic therapy in systemic sclerosis","volume":"47","author":"Distler","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.taap.2011.02.004_bb0070","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/art.22314","article-title":"Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis","volume":"56","author":"Distler","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.taap.2011.02.004_bb0075","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1006\/taap.1993.1069","article-title":"The involvement of Kupffer cells in carbon tetrachloride toxicity","volume":"119","author":"Edwards","year":"1993","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2011.02.004_bb0080","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.freeradbiomed.2007.11.020","article-title":"Novel redox-dependent regulation of NOX5 by the tyrosine kinase c-Abl","volume":"44","author":"El Jamali","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2011.02.004_bb0085","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.tox.2008.06.013","article-title":"Hepatic fibrosis\u2014overview","volume":"254","author":"Friedman","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2011.02.004_bb0090","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2011.02.004_bb0095","doi-asserted-by":"crossref","first-page":"d69","DOI":"10.2741\/887","article-title":"Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell","volume":"8","author":"Gabele","year":"2003","journal-title":"Front. Biosci."},{"key":"10.1016\/j.taap.2011.02.004_bb0100","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/37.3.2465335","article-title":"Estimation of collagen content of liver specimens. Variation among animals and among hepatic lobes in cirrhotic rats","volume":"37","author":"Gascon-Barre","year":"1989","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.taap.2011.02.004_bb0105","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1021\/tx9701790","article-title":"Reactions of 1-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Analytical applications to a colorimetric assay of lipid peroxidation","volume":"11","author":"Gerard-Monnier","year":"1998","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2011.02.004_bb0110","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jacc.2009.04.006","article-title":"Inflammation, growth factors, and pulmonary vascular remodeling","volume":"54","author":"Hassoun","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.taap.2011.02.004_bb0115","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2011.02.004_bb0120","first-page":"1972","article-title":"Approval summary: imatinib mesylate capsules for treatment of adult patients with newly diagnosed philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase","volume":"9","author":"Johnson","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2011.02.004_bb0125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000111092","article-title":"Early imatinib-mesylate-induced hepatotoxicity in chronic myelogenous leukaemia","volume":"118","author":"Kong","year":"2007","journal-title":"Acta Haematol."},{"key":"10.1016\/j.taap.2011.02.004_bb0130","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1056\/NEJMra044389","article-title":"Tyrosine kinases as targets for cancer therapy","volume":"353","author":"Krause","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2011.02.004_bb0135","doi-asserted-by":"crossref","first-page":"17281","DOI":"10.1074\/jbc.M101414200","article-title":"Targeting of the c-Abl tyrosine kinase to mitochondria in the necrotic cell death response to oxidative stress","volume":"276","author":"Kumar","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2011.02.004_bb0140","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1124\/mol.63.2.276","article-title":"Abrogation of the cell death response to oxidative stress by the c-Abl tyrosine kinase inhibitor STI571","volume":"63","author":"Kumar","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.taap.2011.02.004_bb0145","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1365-2362.2006.01620.x","article-title":"A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited","volume":"36","author":"Laleman","year":"2006","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.taap.2011.02.004_bb0150","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/j.1440-1746.2005.03901.x","article-title":"Hydroxyproline content of needle biopsies as an objective measure of liver fibrosis: emphasis on sampling variability","volume":"20","author":"Lee","year":"2005","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.taap.2011.02.004_bb0155","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1126\/science.7892601","article-title":"Tyrosine kinase inhibition: an approach to drug development","volume":"267","author":"Levitzki","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.taap.2011.02.004_bb0160","doi-asserted-by":"crossref","first-page":"6977","DOI":"10.1016\/j.bmc.2010.08.026","article-title":"Structural resemblances and comparisons of the relative pharmacological properties of imatinib and nilotinib","volume":"18","author":"Manley","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.taap.2011.02.004_bb0165","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","article-title":"Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase","volume":"47","author":"Marklund","year":"1974","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.taap.2011.02.004_bb0170","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s10620-006-9117-1","article-title":"Imatinib mesylate (gleevec) hepatotoxicity","volume":"52","author":"Mindikoglu","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.taap.2011.02.004_bb0175","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/niox.2000.0319","article-title":"A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite","volume":"5","author":"Miranda","year":"2001","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.taap.2011.02.004_bb0180","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1293\/tox.17.219","article-title":"Examination of the rat model of liver injury via thioacetamide (TAA) or carbon tetrachloride (CCl4)","volume":"17","author":"Mitsuhashi","year":"2004","journal-title":"J. Toxicol. Pathol."},{"key":"10.1016\/j.taap.2011.02.004_bb0185","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0304-4165(79)90289-7","article-title":"Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver","volume":"582","author":"Moron","year":"1979","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2011.02.004_bb0190","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1440-1746.2006.04231.x","article-title":"Oxidative stress in the development of liver cirrhosis: a comparison of two different experimental models","volume":"21","author":"Natarajan","year":"2006","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.taap.2011.02.004_bb0195","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2005.06.015","article-title":"Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term","volume":"44","author":"Neef","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2011.02.004_bb0200","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1200\/JCO.2004.03.050","article-title":"Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patients","volume":"22","author":"Peng","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2011.02.004_bb0205","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.1038\/sj.onc.1203957","article-title":"The protein tyrosine kinase family of the human genome","volume":"19","author":"Robinson","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.taap.2011.02.004_bb0210","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2307\/3430402","article-title":"Mechanisms of chloroform and carbon tetrachloride toxicity in primary cultured mouse hepatocytes","volume":"69","author":"Ruch","year":"1986","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2011.02.004_bb0215","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1211\/jpp.58.4.0017","article-title":"Cardiotoxic effects of arsenic trioxide\/imatinib mesilate combination in rats","volume":"58","author":"Saad","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.taap.2011.02.004_bb0220","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0160-5402(90)90061-O","article-title":"Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity","volume":"23","author":"Schierwagen","year":"1990","journal-title":"J. Pharmacol. Meth."},{"key":"10.1016\/j.taap.2011.02.004_bb0225","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF03180575","article-title":"Comparison of vitamin E, L-carnitine and melatonin in ameliorating carbon tetrachloride and diabetes induced hepatic oxidative stress","volume":"65","author":"Shaker","year":"2009","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.taap.2011.02.004_bb0230","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1472-8206.2010.00824.x","article-title":"Nilotinib counteracts thioacetamide-induced hepatic oxidative stress and attenuates liver fibrosis progression","volume":"25","author":"Shaker","year":"2011","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.taap.2011.02.004_bb0235","doi-asserted-by":"crossref","first-page":"17237","DOI":"10.1074\/jbc.C000099200","article-title":"Activation of the cytoplasmic c-Abl tyrosine kinase by reactive oxygen species","volume":"275","author":"Sun","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2011.02.004_bb0240","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1124\/jpet.106.113407","article-title":"Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial\/mesenchymal phenotypes: implications for treatment of fibrotic diseases","volume":"321","author":"Vittal","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2011.02.004_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.04-2370com","article-title":"Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo","volume":"19","author":"Wang","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.taap.2011.02.004_bb0250","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/713611034","article-title":"Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model","volume":"33","author":"Weber","year":"2003","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.taap.2011.02.004_bb0255","doi-asserted-by":"crossref","first-page":"13622","DOI":"10.1073\/pnas.0501758102","article-title":"The kinase inhibitor imatinib mesylate inhibits TNF-{alpha} production in vitro and prevents TNF-dependent acute hepatic inflammation","volume":"102","author":"Wolf","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.taap.2011.02.004_bb0260","doi-asserted-by":"crossref","first-page":"G907","DOI":"10.1152\/ajpgi.00420.2004","article-title":"Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats","volume":"288","author":"Yoshiji","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.taap.2011.02.004_bb0265","first-page":"899","article-title":"Amelioration of liver fibrogenesis by dual inhibition of PDGF and TGF-beta with a combination of imatinib mesylate and ACE inhibitor in rats","volume":"17","author":"Yoshiji","year":"2006","journal-title":"Int. J. Mol. Med."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X11000500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X11000500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T16:54:18Z","timestamp":1543942458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X11000500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0041008X11000500"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2011.02.004","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}